Clinical Trial 54363

Berlin, NJ 08009


Summary:

A Phase 3, double-blind, randomized, placebo-controlled, multi-center, fixed-dose, parallel group efficacy and safety in pediatrics (6-17) with Attention-Deficit/ Hyperactivity Disorder (ADHD) using CTx-1301 (dexmethylphenidate)


Qualified Participants Must:

• Be 6 - 17 years old
• Be diagnosed with ADHD
• Be in general good health


Qualified Participants May Receive:

Up to $850 for time and travel


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.